ðæšªæµã§12å°ã ãïŒäžçãæ³šç®ããèåæž¬å®æ©ãåœé¢ã«ææ°æ©åšãå°å ¥ããŸããã

ãAGE Reader muãã§âç³å幎霢âãèŠããåâš
ãåœé¢ã«ææ°æ©åšãå°å ¥ããŸããã
ããã«ã¡ã¯â
ããŸãã¡åŒåžåšå
ç§ã»ç®èç§ã¯ãªãã㯠é¢é·ã®å±±å£è£ç€Œã§ãã
ã€ãã«ââ
ð£æšªæµã§ããŸã å°å
¥æ°10å°æªæºïŒ
äžçãæ³šç®ããâèåç©è³ªâAGEsïŒçµæ«ç³åç£ç©ïŒã枬å®ã§ãã
â
äžçæå
端ã®å»çæ©åšãAGE Reader muããåœé¢ã«å°å
¥ããŸããð
ðŽ 1å500åïŒçšèŸŒïŒã»äºçŽäžèŠïŒ
ð 2025幎7æ28æ¥ïŒæïŒããæž¬å®ã¹ã¿ãŒãããããŸãïŒ
ãã²ãã®æ©äŒã«ãããªãã®âããã ã®å¹Žéœ¢âããã§ãã¯ããŠã¿ãŸãããïŒ

ð§¬AGEsïŒçµæ«ç³åç£ç©ïŒã£ãŠãªã«ïŒ
AGEsãšã¯ãç³è³ªãšã¿ã³ãã¯è³ªãäœå
ã§çµã³ã€ãããšã§çãŸãããèåç©è³ªãã§ãã
ãããèç©ãããšâŠ
â ã·ãã»ã·ã¯ã»ããã¿ãªã©ã®èèå
â åè硬åãç³å°¿ç
ãèªç¥çãCOPDãªã©å€ãã®çæŽ»ç¿æ
£ç
â äžåºŠã§ãããšå
ã«æ»ãã«ããïŒïŒé«è¡ç³ã®âéºç£âãšãïŒ
ãšãã£ããã©ãã«ã®âå å¶âã«ãªãããšãããã£ãŠããŸããã
ðAGE Reader muã§äœããããã®ïŒ
ãã®æ©æ¢°ã¯ãç®èã«å
ãåœãŠãã ãã®é䟵襲çã»å³ææž¬å®âš
ãããïŒ
â
ãã£ã12ç§ã§çµæãåºã
â
æ¡è¡ã»çã¿ãŒã
â
äœã®ãå
ãªãèåãïŒç³å幎霢ãããã
ð æž¬å®å€ã1åäœäžããããšã«âŠ
- 2åç³å°¿ç ã»å¿è¡ç®¡ç ãªã¹ã¯ã 3åã«äžæ
- æ»äº¡ãªã¹ã¯ã ãªããš5åã«äžæïŒâ»Diabetologiaèª 2004ïŒ
ãšãããéåžžã«é«ãäºç¥ç䟡å€ãæã€å»çæ©åšã§ãð©º
ðºæšªæµåžå ã§ã®å°å ¥ã¯ãããããïŒ
AGE Reader muã¯æ¬§å·ã®èšåºç ç©¶ã«åºã¥ãå»çæ©åšãšããŠäžççã«ä¿¡é ŒãããŠããã
â
çŸåšã暪æµåžå
ã§ã®å°å
¥ã¯ãŸã 12å°ïŒ2025幎7æ23æ¥ïŒã
â»ç§ãã¡ã®èª¿æ»æç¹ã§ã¯ãåœé¢ã¯æ°å°ãªãå¯Ÿå¿æœèšã®ã²ãšã€ã§ãã
ããã¯ãå¥åº·ã®èŠããåããå»çã®çŸå Žã«å°å ¥ãããæ¬ç©ã®äºé²å»çã§ãð±

ðä¿¡é Œããããšããã³ã¹ã®æ°ã
ð¬AGEsãšçŸæ£ã®é¢ä¿ã«ã¯å€æ°ã®è«æãååšããŸãã
- æ¥æ¬äºº1äžäººã察象ã«ããç ç©¶ã§ã¯ã
ãå«ç ã»éåäžè¶³ã»ç¡ç äžè¶³ã»çããã®ã®éé£ãAGEsé«å€ãšæç¢ºã«é¢é£ïŒJ Int Med Res, 2018ïŒ - AGEsã®å€ã¯ãèŠãç®å¹Žéœ¢ãšãææã«çžé¢ïŒPharma Medica, 2015ïŒ
- COPDæ£è ã§ã¯FEV1ã®äœäžãšAGEså€ãé¢é£ïŒæ¬§å·åŒåžåšåŠäŒ ERSããŒã¿ïŒ
- ç³å°¿ç å䜵çã®éç床ãšãçžé¢ïŒJASN, 2005ïŒ
- ã³ã©ãŒã²ã³ããããæåã§AGEsã15ïŒ äœäžïŒBiosci Biotech Biochem, 2023ïŒ
ã€ãŸããAGEså€ã®ç®¡çïŒçæŽ»ç¿æ £ãšçŸæ£äºé²ã«çŽçµããææšãªãã§ãã
ð¡ãªãä»ããç³å幎霢ããæž¬ãã®ãïŒ
ðµ ã·ããããã¿ãæ°ã«ãªãâŠ
ðšââïž å¥åº·èšºæã§ã¯åé¡ãªããã©ããªããšãªãç²ããããâŠ
ð è¬ã«é Œãåã«ãçæŽ»ãèŠçŽãããâŠ
ãããªããªããžããããã®æ€æ»ãããããããŸãð
ç³å幎霢ãç¥ãããšã¯ããèªåã®æªæ¥ãå€ããç¬¬äžæ©ãã§ãã
ð¥åœé¢ã§ã®æž¬å®ã®æµã
- ã¹ã¿ããã«ã声ãããã ããïŒäºçŽäžèŠïŒ
- èã®å åŽã«ã»ã³ãµãŒãåœãŠãã ã
- 12ç§ã§çµæã衚瀺ãããŸã
- ã¹ã³ã¢ãšä»åŸã®ç掻ã¢ããã€ã¹ããäŒãããŸãïŒ
ð§ŸæéïŒ500åïŒçšèŸŒïŒ
ð2025幎7æ28æ¥ïŒæïŒããåä»éå§ãšãªããŸãâš
â»æ¥çŒãçŽåŸãä¿æ¹¿å€ã»æ¥çŒãæ¢ããå¡ã£ãŠããå Žåã¯æž¬å®ã§ããŸããã®ã§ãäºæ¿ãã ããã

ðæåŸã«
ãèåããšãçæŽ»ç¿æ
£ç
ãã¯ãåã£ãŠãåããªãé¢ä¿ã«ãããŸãã
ã§ããã®å
åã¯ãæ°ã¥ãã«ãããã®ã
ã ããããââ
ð¬âä»âã®ç¶æ
ãç¥ã£ãŠãæªæ¥ãå®ãã
ãã®ãã£ãããšããŠãAGE Reader muã¯éåžžã«æå¹ã§ãã
âš500åã§ã§ãããæªæ¥ãžã®å¥åº·æè³
ãŸãã¯ãæ°è»œã«ãã¹ã¿ãããŸã§ã声ãããã ãããâºïž
æçš¿è ãããã£ãŒã«

-
ããã æŽãã©ã
â å»åŠïŒåŒåžåšã»ã¢ã¬ã«ã®ãŒ
â¡ çæŽ»ïŒè žã»æž©æŽ»ã»é£ã»ç¡ç ã»è
⢠幞çŠïŒåãæ¹ã»ç°å¢ã»åèž
âç æ°ã蚺ãã ãã§ãªãã人ããŸãããšèšºããâ
ââãã®æããèžã«ãåŠã³ãç¶ããŠããŸãã
å»åŠçæ ¹æ Ã çæŽ»ç¿æ £ à å¿ã®è±ãã
äžäœäžäœã®å»çãããããŠããŸãã
è³æ ŒïŒ
ïŒå»åŠã»å»çïŒå»åŠåå£«ãæ¥æ¬åŒåžåšåŠäŒèªå®åŒåžåšå°éå»ãæ¥æ¬ã¢ã¬ã«ã®ãŒåŠäŒèªå®ã¢ã¬ã«ã®ãŒå°éå»ãæ¥æ¬åæ¯åŠäŒèªå®åæ¯å°éå»ãæ¥æ¬å ç§åŠäŒèªå®å ç§å»ãæ¥æ¬åæ¯åŠäŒèªå®åžå ¥çæ³ãšãã¹ããŒã
ïŒäºé²å»åŠã»ä»£æ¿å»çã»ç°å¢ïŒ
æ©èœç骚ç€åºçãšã¯ãµãµã€ãºpfilAtesâ¢èªå® ã€ã³ã¹ãã©ã¯ã¿ãŒåœéè³æ Œâ NEWâš
ã«ã©ãå説®ãã¹ã¿ãŒã»ãžã§ãã©ã«
ç°å¢ç ç°å¢äººæèªå®äºæ¥ æ¥æ¬ç°å¢ç®¡çåäŒèªå®ç°å¢ç®¡çå£«ãæŒ¢æ¹ã³ãŒãã£ããŒã¿ãŒãå é¢çŸå®¹å»åŠè²¡å£å ¬èªãã¡ã¹ãã£ã³ã°ã«ãŠã³ã»ã©ãŒãæ¥æ¬ã»ã«ãã¡ã³ããã³ã¹åäŒèªå®è žå ç°å¢ç®¡ç士ãè žå ç°å¢è§£æå£«ãæ¥æ¬æž©æŽ»åäŒèªå®æž©æŽ»å£«ãè¬è³èª¿æŽåž«ã管çå¥åº·æ é€ã€ã³ã¹ãã©ã¯ã¿ãŒãé£è²å¥åº·ã¢ããã€ã¶ãŒãæ¥æ¬ãã§ã ããã¯ãã€ã¹ã¿ãŒåäŒå ¬èªãã§ã ããã¯ãã€ã¹ã¿ãŒÂ®äžçŽãå ¬èªåп޻ãã€ã¹ã¿ãŒÂ®Basicãæ¥æ¬ã¹ãã³ã±ã¢åäŒèªå®ã¹ãã³ã±ã¢ã¢ããã€ã¶ãŒãã¡ã³ã¿ã«å£«å¿çã«ãŠã³ã»ã©ãŒãã¢ãŒãŠã«ãŽã§ãŒãã¢ããã€ã¶ãŒãå¿«ç ã»ã©ãã¹ããå®ç ã€ã³ã¹ãã©ã¯ã¿ãŒ
ïŒæåã»ç掻ïŒ
æ¥æ¬åèžåäŒèªå®ããŒãºã»ã³ã³ã·ã§ã«ãžã¥ãããŒãºãœã ãªãšÂ®ïŒãã©è³æ ŒïŒ
ïŒåè³æŽïŒ
第74忥æ¬ã¢ã¬ã«ã®ãŒåŠäŒåŠè¡å€§äŒãåãæ¹æ¹é©æšé²å¥šå±è³ãåè³
ææ°ã®æçš¿
ããã æŽãã©ã2026幎3æ1æ¥ã芳æŠèšã暪æµBUNTAIãç±çïŒãããã³ãã³S/JãªãŒã°TOP4ã§æãããæ¬æ°ããããå
æ°ã
ããã æŽãã©ã2026幎3æ1æ¥ðèå°ã倧å°ã®åãã芳㊠â èšèãã®ãã®ã®åã«å§åãããæé
ã¯ãªããã¯ã ãã2026幎2æ28æ¥ðžãã奜è©ã«ã€ãå»¶é·æ±ºå®ãæééå®ãè±ç²ç倿¥ã3æãç¶ç¶ããŸãïŒ
ããã æŽãã©ã2026幎2æ26æ¥ð¿äººã¯ãçããŠããããã«ãçãç¶ãã


